Stroke Risk Factor Status and Use of Stroke Prevention Medications Among Hispanic/Latino Adults in HCHS/SOL
نویسندگان
چکیده
منابع مشابه
Alcohol Use and Risk of Ischemic Stroke Among Older Adults
Background and Purpose—The association of light to moderate alcohol consumption with risk of ischemic stroke remains uncertain, as are the roles of potentially mediating factors and modification by apolipoprotein E (apoE) genotype. Methods—We studied the prospective association of alcohol consumption and risk of ischemic stroke among 4410 participants free of cardiovascular disease at baseline ...
متن کاملEvaluation of Homocysteine Level as a Risk Factor among Patients with Ischemic Stroke and Its Subtypes
Background: Epidemiological research has shown that increased total homocysteine (tHcy) levels are associated with an increased risk of thromboembolic disease; however, controversy still exists over which subtype of stroke is allied to hyperhomocysteinemia. This study aimed to investigate whether elevated tHcy is an independent risk factor for ischemic stroke and to compare tHcy levels in patie...
متن کاملIntensive risk factor control in stroke prevention
Stroke prevention is an urgent priority because of the aging of the population and the steep association of age and risk of stroke. Direct costs of stroke are expected to more than double in the US between 2012 and 2030. By getting everything right, patients can reduce the risk of stroke by 80% or more; however, getting everything right is a tall order. Roughly in order of importance, this requ...
متن کاملRole of pentoxyphiline in stroke prevention
Anti-platelet agents such as aspirin and dipyridamole are main factors to prevent stroke in high-risk people. Pentoxyphiline has been reported as a red blood cell aggregation antagonist to prevent stroke. We evaluated the role of pento-xyphiline as an adjunct therapy to decrease risk of stroke in patients who were under treatment with aspirin or dipyridamole. A 5-years open labeled clinical tri...
متن کاملUse of antithrombotic medications among elderly ischemic stroke patients.
BACKGROUND The use of antithrombotic medications after ischemic stroke is recommended for deep vein thrombosis prophylaxis and secondary stroke prevention. We assessed the rate of receipt of these therapies among eligible ischemic stroke patients age ≥65 years and determined the effects of age and other patient characteristics on treatment. METHODS AND RESULTS The analysis included Medicare f...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 2021
ISSN: 0039-2499,1524-4628
DOI: 10.1161/strokeaha.120.031216